Options volume is relatively light, with 35k contracts traded and calls leading puts for a put/call ratio of 0.77, compared to a typical level near 0.72. Implied volatility (IV30) dropped 0.76 to 29.77, in the highest 10% of observations over the past year, suggesting an expected daily move of $0.42. Put-call skew flattened, suggesting a modestly bullish tone.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s Hold Rating: Balancing Policy Uncertainties and Long-Term Growth Prospects
- U.S. biotech companies debate relocating trials outside U.S., Reuters reports
- Terns Pharmaceuticals price target lowered to $15 from $26 at BMO Capital
- Trump’s drug-price crackdown may lead to minor concessions, WSJ reports
- Pharma Stocks Rally despite Trump’s Plan to Cut Drug Prices